Spine surgeons' total compensation averages $7.8k
The total compensation of spine surgeons is about $777,262, and $728,006 for neurosurgeons. Click here to view more statistics on spine surgeon and neurosurgeon salary, compensation and work RVUs.
Physician-owned ASCs driving lumbar spine fusion market growth
Through 2020, a Market Report Worlds analysis found the lumbar spine fusion market will likely grow substantially. The growing number of physician-owned ambulatory surgery centers is fueling growth. The report notes the expanded use of surface modified titanium in spinal implants is also spurring market expansion.
DePuy Synthes boosts spine offering with acquisition of Interventional Spine technology
Raynham, Mass.-based DePuy Synthes acquired Interventional Spine's expandable cage technology. With this acquisition, DePuy Synthes strengthens its open and minimally invasive spine solutions. DePuy Synthes is also acquiring Interventional Spine's facet screw system for open and percutaneous spine surgery.
World Spine Care overview on 4 projects to promote spine health in underserved countries
Volunteers from five continents came together to establish World Spine Care, an organization dedicated to providing evidence-based spine care to low- and middle-income countries. The organization's research committee approves and oversees projects for the underserved populations around the world and provides education to prevent spinal disability in the future. Read about the projects here.
Mazor Robotics receives order for 3 Mazor X systems
Caesarea, Israel-based Mazor Robotics received an order for three of its Mazor X systems from a mid-Atlantic healthcare organization. The organization will use the systems at three of its medical centers. Mazor will release the total number of system orders on Jan. 5, 2017.
Dr. Toby Cosgrove withdraws name for Trump's VA spot
Toby Cosgrove, MD, CEO of Cleveland Clinic, withdrew his name to head the Department of Veterans Affairs under President-elect Donald Trump's administration. While Mr. Trump's chief aides wanted Dr. Cosgrove to take on the VA role, they told Dr. Cosgrove to tell them if he would commit to the job before sending him a formal offer.
FDA approves 1st drug to treat spinal muscular atrophy
The FDA approved Spinraza, the first approved drug to treat patients with spinal muscular atrophy. Physicians inject Spinraza into the fluid surrounding a patient's spinal cord. The FDA approved the drug for use in both children and adults with SMA.
The CORE Institute's Dr. Ali Araghi leads patient enrollment for Zyga Technology's study
Phoenix-based The CORE Institute's Ali Araghi, DO, leads the nation in patient enrollment for Zyga Technology's EVoluSIon Study. Of 64 patients, Dr. Araghi has enrolled 11 patients in the Phoenix area. The patients experience pain in their sacroiliac joint, and received Zyga's SImmetry implant.
More articles on spine:
Fusion vs. decompression for lumbar degenerative spondylolisthesis: 5 observations
St. Anthony's Center for Interventional Pain Management adds pain management physician Dr. Brian Parks — 4 highlights
6 spine surgeons & neurosurgeons on the move in December 2016